Yunnan Baiyao Group Co., Ltd.

Yunnan Baiyao Group Co., Ltd. has recently experienced an evaluation adjustment reflecting changes in its financial metrics and market position. Key indicators such as P/E ratio, Price to Book Value, and dividend yield suggest a stable operational framework, despite flat financial performance and recent challenges.

Yunnan Baiyao Group Co., a key player in the Pharmaceuticals & Biotechnology sector, faced a decline on March 23, 2026, amid broader market trends. Despite recent pressures, the company has shown resilience over the past year, supported by solid financial metrics and a notable net profit for the first nine months.

Yunnan Baiyao Group Co., Ltd. has recently experienced a change in its evaluation, reflecting an improved assessment of its financial metrics. Key indicators include a P/E ratio of 19, a dividend yield of 4.43%, and strong operational performance with a return on equity of 12.59%.